AS

Adh Surgery

BE1023.834.307

About Adh Surgery

Adh Surgery is a private limited company (BV/SRL) based in Elsene, founded in 2025. For the 2025 financial year, Adh Surgery reported a profit of €18,276. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €25,612. Equity stands at €20,443, a solvency ratio of 53%.

Juridical situation
Normal situation
Company number
1023.834.307
Founding date
Founded on 28-05-2025
EUID number
BEKBOBCE.1023.834.307
Type of enterprise
Rechtspersoon
Location
Washingtonstraat 123/4 Elsene 1050
Juridical form
BV — Private limited company (BV/SRL)
Activities
Signals
Profitable
Low risk
Good liquidity
Positive cashflow
Positive EBITDA

Financial ratios

Profit
€ 18K
Equity
€ 20K
Gross margin
€ 26K
Health
Solvability > 25%
53.4%
Liquidity > 1.0
1.98
Profitability > 0%
89.4%
2025
Gross margin
€ 26K
EBITDA
€ 26K
Profit
€ 18K
Equity
€ 20K
Solvability
53.44%
Debt
€ 18K
Cash
€ 35K

Frequently asked questions

Answers to the most common questions about Adh Surgery, based on official government data and the filed annual accounts.

What is the VAT number of Adh Surgery?

The VAT number of Adh Surgery is BE1023.834.307.

When was Adh Surgery established?

Adh Surgery was founded in 28-05-2025.

What is the official address of Adh Surgery?

The official address of Adh Surgery is Washingtonstraat 123/4 Elsene 1050.

What is the legal form of Adh Surgery?

The juridical form of Adh Surgery is Private limited company (BV/SRL).

What is the annual revenue of Adh Surgery?

The 2025 accounts of Adh Surgery do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Adh Surgery a reliable company?

Adh Surgery is a registered Rechtspersoon with company number 1023.834.307 and can be verified through the official CBE database.

What is the credit limit of Adh Surgery?

The estimated credit limit of Adh Surgery is €28,366.

Is Adh Surgery still active?

Adh Surgery currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources